MARKET

CBMG

CBMG

Cellular
NASDAQ

Real-time Quotes | Nasdaq Last Sale

17.45
-0.63
-3.48%
Opening 14:44 11/22 EST
OPEN
18.10
PREV CLOSE
18.08
HIGH
18.10
LOW
17.35
VOLUME
25.94K
TURNOVER
--
52 WEEK HIGH
20.63
52 WEEK LOW
10.98
MARKET CAP
354.87M
P/E (TTM)
-7.2317
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of CBMG and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

CBMG News

  • CBMG: Data from Multiple Myeloma Trial to be Presented at ASH
  • Zacks Small Cap Research.11/15 09:50
  • Benzinga's Top Upgrades, Downgrades For November 12, 2019
  • Benzinga.11/12 14:37
  • SunTrust sees 16% upside in Amgen in premarket analyst action
  • Seeking Alpha - Article.11/12 14:12
  • 10 Biggest Price Target Changes For Tuesday
  • Benzinga.11/12 13:14

More

Industry

Biotechnology & Medical Research
+1.69%
Pharmaceuticals & Medical Research
+0.76%

Hot Stocks

Name
Price
%Change

About CBMG

Cellular Biomedicine Group Inc. is engaged in the development of cell therapy technologies. The Company develops cell therapies for the treatment of cancer and degenerative diseases. The Company conducts immuno-oncology and stem cell clinical trials in China using products from the goods manufacturing practices (GMP) laboratory. The Company's technology includes platforms, such as Immune Cell therapy for treatment of broad range of cancers using Vaccine, T Cells Receptor (TCR) clonality analysis technology and T Central Memory Cell (Tcm) preparation methodologies, Chimeric Antigen Receptor T cell (CAR-T), and human adipose-derived mesenchymal progenitor cells (haMPC) for treatment of joint and autoimmune diseases, with primary research and manufacturing facilities in China. The Company is focused on developing and marketing cell-based therapies based on its cellular platforms, to treat serious chronic and degenerative diseases, such as cancer, orthopedic diseases.
More

Webull offers Cellular Biomedicine Group Inc (CBMG) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.